Literature DB >> 7641044

Correction of high myopia with the Worst myopia claw intraocular lens.

M Landesz1, J G Worst, J V Siertsema, G van Rij.   

Abstract

BACKGROUND: Phakic anterior chamber lenses is one of the modalities used to correct high myopia. We report the initial results of our prospective study on the Worst myopia claw intraocular lens (IOL) that is fixated to the anterior iris.
METHODS: We studied 35 eyes in 18 patients with a preoperative myopia ranging from -6.00 to -28.00 diopters (D). The follow up ranged from 6 months (n = 15) to 12 months (n = 20).
RESULTS: In 26 (74.3%) eyes, the postoperative spherical equivalent refractive error was within 1.00 D of emmetropia. The mean refraction was stable between 1 to 2 months and 12 months. The mean spectacle-corrected visual acuity improved from 20/50 to 20/40. The straylight measurements did not show a significant increase postoperatively (p = .64). The mean endothelial cell loss was 5.6% (range, +6.3% to -22.6%) at 6 months, and 8.9% (range, +0.77% to -23.5%) at 12 months. We did not encounter major complications.
CONCLUSION: Implanting a Worst myopia claw IOL in high myopic eyes resulted in a stable, reasonably accurate refractive outcome. This group of patients will be followed longer because of concern over ocular complications with this technique.

Entities:  

Mesh:

Year:  1995        PMID: 7641044     DOI: 10.3928/1081-597X-19950101-07

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  3 in total

1.  [History of the development of intraocular lenses].

Authors:  G U Auffarth; D J Apple
Journal:  Ophthalmologe       Date:  2001-11       Impact factor: 1.059

2.  Artisan phakic intraocular lens for correcting high myopia.

Authors:  Tova Lifshitz; Jaime Levy; Isaac Aizenman; Itamar Klemperer; Shmuel Levinger
Journal:  Int Ophthalmol       Date:  2005-09-29       Impact factor: 2.031

3.  Clear lens extraction for patients who are unfit for laser-assisted in situ keratomileusis and implantable contact lenses in central Indian population.

Authors:  Rajesh Subhash Joshi
Journal:  Indian J Ophthalmol       Date:  2020-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.